Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead

• Autor(a) principal: Boia, Raquel
• Data de Publicação: 2020
• Outros Autores: Ruzafa, Noelia, Aires, Inês Dinis, Pereiro, Xandra, Ambrósio, António Francisco, Vecino, Elena, Santiago, Ana Raquel
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10316/90486; https://doi.org/10.3390/ijms21072262
• topic: retinal ganglion cells; neurodegeneration; axonal regeneration; neuroprotection; optic neuropathies

The retinal ganglion cells (RGCs) are the output cells of the retina into the brain. In mammals, these cells are not able to regenerate their axons after optic nerve injury, leaving the patients with optic neuropathies with permanent visual loss. An effective RGCs-directed therapy could provide a beneficial effect to prevent the progression of the disease. Axonal injury leads to the functional loss of RGCs and subsequently induces neuronal death, and axonal regeneration would be essential to restore the neuronal connectivity, and to reestablish the function of the visual system. The manipulation of several intrinsic and extrinsic factors has been proposed in order to stimulate axonal regeneration and functional repairing of axonal connections in the visual pathway. However, there is a missing point in the process since, until now, there is no therapeutic strategy directed to promote axonal regeneration of RGCs as a therapeutic approach for optic neuropathies.